JACQUELYN TRAN: Open Payments
NPI 1366798027 · MANHATTAN BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,755 in 109 payments from 22 companies in 2025. Trend: 2023 $2,062 · 2024 $1,841 · 2025 $1,755
Food & beverage: $1,755
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 13 | $354 |
| MAYNE PHARMA COMMERCIAL LLC | 37 | $163 |
| Incyte Corporation | 7 | $161 |
| ANI Pharmaceuticals, Inc. | 5 | $120 |
| UCB, Inc. | 4 | $106 |
| PFIZER INC. | 5 | $102 |
| ABBVIE INC. | 5 | $92 |
| Galderma Laboratories, L.P. | 4 | $83 |
| Arcutis Biotherapeutics, Inc. | 4 | $73 |
| Janssen Biotech, Inc. | 3 | $70 |
Products named: DUPIXENT, OPZELURA, Bimzelx, CIBINQO, Veregen, Zoryve, BOTOX, TREMFYA.
Industry payments across CA — which companies pay providers there.
